Assessment of Factors Contributing to Medicine Expiry in Rwanda: Case of the Medical Procurement and Production

Theogene Hakuzimana1,2, Pierre Claver Kayumba1, Innocent Hahirwa3

  • 1EAC Regional Centre of Excellence for Vaccines, Immunization, and Health Supply Chain Management, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Abstract

Insights

Poor supply chain management leads to significant medicine expiry losses at Rwanda's Medical Procurement and Production Division (MPPD). Addressing these issues is crucial to reduce waste and improve healthcare delivery.

Area of Science:

  • Public Health
  • Supply Chain Management
  • Pharmaceutical Management

Background:

  • Despite efforts to improve supply chain performance in Rwanda, the Medical Procurement and Production Division (MPPD) faces significant losses due to medicine expiry.
  • Poor inventory management practices contribute to substantial wastage of essential medicines.

Purpose of the Study:

  • To identify factors contributing to medicine expiry at the MPPD.
  • To develop recommendations for enhancing medicine supply chain management and reducing expiry-related losses.

Main Methods:

  • A descriptive cross-sectional study was conducted with 25 respondents at the MPPD.
  • Data was collected using questionnaires and a review of inventory and expiry reports from 2014-2018.
  • The study targeted pharmacists and warehouse personnel involved in medicine management.

Main Results:

  • Over a five-year period (2014-2018), expired medicines at MPPD were valued at RWF 6,046,778,655.
  • HIV commodities constituted the largest share (53.3%) of expired products.
  • Key factors contributing to expiry were supply chain management (90%), other factors (73%), poor storage (68%), and excessive supply (67%).

Conclusions:

  • Supply chain management components are highly vulnerable and significantly contribute to medicine expiration at MPPD.
  • Improvements needed include adherence to standard operating procedures, enhanced personnel skills in supply chain management, and better stakeholder communication.
  • Empowering the procurement unit and ensuring timely stock replenishment and distribution are essential to mitigate medicine expiry.

Related Concept Videos

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
254
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
534